Cargando…
SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway
BACKGROUND: Herbal medicines have been used in cancer treatment, with many exhibiting favorable side effect and toxicity profiles compared with conventional chemotherapeutic agents. SH003 is a novel extract from Astragalus membranaceus, Angelica gigas, and Trichosanthes Kirilowii Maximowicz combined...
Autores principales: | Choi, Yu-Jeong, Choi, Youn Kyung, Lee, Kang Min, Cho, Sung-Gook, Kang, Soo-Yeon, Ko, Seong-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142381/ https://www.ncbi.nlm.nih.gov/pubmed/27927199 http://dx.doi.org/10.1186/s12906-016-1490-5 |
Ejemplares similares
-
SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016) -
SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes
por: Choi, Youn Kyung, et al.
Publicado: (2016) -
Herbal Extract SH003 Suppresses Tumor Growth and Metastasis of MDA-MB-231 Breast Cancer Cells by Inhibiting STAT3-IL-6 Signaling
por: Choi, Youn Kyung, et al.
Publicado: (2014) -
State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent
por: Lee, Kangwook, et al.
Publicado: (2022) -
SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022)